GE Healthcare plans to highlight research on automated breast ultrasound (ABUS) at the European Society of Breast Imaging (EUSOBI) annual meeting in Paris.
In a study published in the European Journal of Radiology, Swedish researchers found that ABUS significantly improved cancer detection in women with dense breast tissue when used with mammography.
Dr. Brigitte Wilczek and colleagues conducted the European Asymptomatic Screening Study (EASY) to evaluate the impact of ABUS used with full-field digital screening mammography (FFDM) in 1,668 women ages 40 to 74 with dense breasts (EJR, September 2016, Vol. 85:9, pp. 1554-1563).
The group found a 57% relative increase in breast cancer detection in dense breast tissue -- or 6.6 cancers detected per 1,000 women screened, compared with 4.2 cancers per 1,000 women screened with mammography alone.
The researchers also found that the recall rate for ABUS and digital mammography combined was 0.9% higher than the recall rate of mammography alone.
GE plans to feature the next generation of its Invenia ABUS system at the EUSOBI meeting, the company said.
